Sabrina X. Van Ravenstein

Sabrina X. Van Ravenstein

Auto-generated profile, based on publicly available information

Sabrina X. Van Ravenstein

Department of Biochemistry Vanderbilt University School of Medicine Nashville TN USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in The EMBO Journal
Verified
Journal Article
Closed access
SRSabrina X Van Ravenstein
Sabrina X Van Ravenstein
KMKavi Mehta
Kavi Mehta
TKTamar Kavlashvili
Tamar Kavlashvili
JBJo Ann W Byl
Jo Ann W Byl
RZRunxiang Zhao
Runxiang Zhao
JDJames M Dewar
James M Dewar

19 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
TKTamer Saad Kaoud
Tamer Saad Kaoud
WJWilliam H. Johnson
William H. Johnson
NENancy Danielle Ebelt
Nancy Danielle Ebelt
APAndrea Piserchio
Andrea Piserchio
DZDiana Zamora-Olivares
Diana Zamora-Olivares
Kevin N. DalbyKevin N. Dalby
Kevin N. Dalby
Recently, the targeting of ERK with ATP-competitive inhibitors has emerged as a potential clinical strategy to overcome acquired resistance to BRAF and MEK inhibitor combination therapies. In this study, we investigate an alternative strategy of targeting the D-recruitment site (DRS) of ERK. The DRS is a conserved region that lies distal to the active site and mediates ERK–protein interactions. We demonstrate that the small molecule BI-78D3 binds to the DRS of ERK2 and forms a covalent adduct with a conserved cysteine residue (C159) within the pocket and disrupts signaling in vivo. BI-78D3 does not covalently modify p38MAPK, JNK or ERK5. BI-78D3 promotes apoptosis in BRAF inhibitor-naive and resistant melanoma cells containing a BRAF V600E mutation. These studies provide the basis for designing modulators of protein–protein interactions involving ERK, with the potential to impact ERK signaling dynamics and to induce cell cycle arrest and apoptosis in ERK-dependent cancers.